UCB

In the latest article of our Exploring Epilepsies series, we’re exploring the unmet need in uncontrolled #seizures and the new Rapid and Early Seizure Termination (REST) concept outlined in EpiDisorders https://lnkd.in/eR5kbeRM

UCBCares® is the Service Center of UCB. We are here to answer your specific questions on your UCB medication and provide you with related information and materials. UCBCares® does not replace the conversation or the medical advice of the treating doctor or is not meant to promote the medicines of UCB. #UCBCares, #Neurology, #Neurologicalcondition

We're excited to share the latest updates on our groundbreaking gene therapy facility in Braine-l'Alleud, Belgium. This state-of-the-art facility not only represents a significant investment in Belgium but also stands as an epitome of innovation and environmental sustainability. This project broadens our horizons, allowing us to discover and develop revolutionary cures for severe diseases and enhance our development and manufacturing capabilities. Notably, it will create over 100 new highly skilled jobs. Join us in this exciting journey as we transform the future of disease treatment. For more details, please visit our career page https://lnkd.in/garwHTg While we are incredibly proud of the strides we've made, we understand that the path to groundbreaking advancements is paved with collective effort and collaboration. Our commitment to addressing the unmet needs of patients worldwide drives us forward every single day. We are deeply grateful to our dedicated team of scientists, researchers, and partners whose hard work and passion make milestones like this possible. As we continue this journey, we remain focused on not just the outcomes but also on the people whose lives we aim to transform. Together, we aspire to build a future where innovative treatments can offer hope and tangible benefits for those affected by severe diseases. Stay tuned for more updates as we progress, and thank you for being part of our mission. For more details, check out our latest story https://lnkd.in/eTXMNPN6 #Progress #Collaboration #Hope #GeneTherapy

Bart is an Upstream Process Lead Engineer working on UCB’s exciting Genesis project. Find out more about a day in his life as he innovates in the field of gene therapy now, and in the future.    Whether he’s taking the time for deep focus, connecting with colleagues over a freshly cooked lunch or running checks on equipment, his experience at UCB supports him and sets him up for success in his day-to-day activities and career.    At UCB we have a strong human focus. We’re committed to the wellbeing of our employee community and strive to make this a workplace where people enjoy meaning and balance.    https://lnkd.in/dHkyid5y #MakeYourMarkForPatients #TeamUCB #PharmaJobs 

Hellen shares her experience navigating pregnancy and breastfeeding while living with psoriasis. Her story is reflective of many women living with #ChronicDisease and the impact on their reproductive health journey.  Women deserve to have clear, evidence-based guidance on managing their condition while they are pregnant or breastfeeding to optimize their health and the health of their babies. New recommendations developed by the BRIDGE Commission, a multidisciplinary group of experts, provide practical, action-oriented solutions to overcome the information gaps that affect women living with chronic disease. Learn more and read the full report: https://lnkd.in/ekgvNzcp #WomensHealth #HealthEquity #BRIDGE4WomensHealth

UCB´s Service Center is called UCBCares®. Its team is here to support you by answering your questions and provide helpful information and materials around UCB medicines. UCBCares® does not replace the conversation or the medical advice of the treating doctor or is not meant to promote the medicines of UCB. #UCBCares, #Neurology, #Neurologicalcondition

Discover how UCB is championing a better future for women with epilepsy. From tackling info gaps to strategic collaborations, Andrea Wilkinson - Global Head of Epilepsy & Rare Syndromes Patient Engagement - takes us through how we are making a difference. https://lnkd.in/eMa8jD2f #Epilepsy #ExploringEpilepsies

At UCB, we're committed to elevating the standard of care by going beyond the science. Our FASTRAX program exemplifies this commitment, addressing the critical issue of delayed diagnosis of axial spondyloarthritis (axSpA). By leveraging our expertise, technology, and stakeholder collaboration, we're transforming the patient journey from the first signs of symptoms to timely diagnosis and treatment. Learn more about our innovative solutions and how we're making a real impact on the lives of those living with axSpA. #HealthcareInnovation #Rheumatology #PatientCare #FASTRAX #UCB https://lnkd.in/eje4iMtD

We are delighted to share that last night in London, UCB in partnership with Syneos Health, received a Highly Commended accolade in the Progress Award in Healthcare and Scientific Communications at the prestigious Communique Awards. Our work in AI Change Management was recognised for its progressive and people-first nature, increasing UCB’s adoption of generative AI technologies across communications to transform the way we deliver for patients and the business. This achievement highlights our commitment to innovation and the continuous advancement of healthcare communications. A big thank you to everyone involved in this journey. Let’s continue pushing boundaries and making a difference! #communique #communiqueawards24 #healthcommunications

Navigating the path to starting a family presents complex challenges for women living with epilepsy. Read more in this Exploring Epilepsies series on how we're helping drive change https://lnkd.in/eMa8jD2f #Epilepsy #ExploringEpilepsies